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Delivering Effective Care through Mobile Apps: Findings 
from a Multi-Stakeholder Design Science Approach  
Abstract. In this paper, we use a design science approach to develop a mobile 
app for lung cancer patients that facilitates their interactions with their clini-
cians, manages and reports on their health status, and provides them access to 
medical information/education. This paper contributes to the information sys-
tems literature by demonstrating the value of design science research to co-
create solutions that advance health care outcomes through technological inno-
vations. The design process engaged a diverse cast of experts and methods, 
such as a survey of oncologists and cancer patients, a workshop, roundtables 
and interviews with leading patient and clinician association representatives and 
focus groups, including two panels each of clinicians and cancer patients. Our 
approach also develops actionable knowledge that is grounded in evidence from 
the field, including design guidelines that recapitulate what we learned from the 
design-testing-redesign cycles of our artefact. 
Keywords: healthcare, m-health, cancer care, value co-creation 
1 Introduction 
Mrs. Rossi1 found it difficult to describe how angry, depressed, and betrayed by her 
own body she felt when she was initially diagnosed with lung cancer almost 3 years 
ago. These feelings intensified once she began therapy.  
“When necessary, I would prefer to easily communicate with my clinician because 
he’s the only one who really understands how I feel and explains what I should do 
or expect. However, I know that he’s very busy and takes care of many patients. I 
am embarrassed to call him whenever I feel like I need to speak to him”. 
Mrs. Rossi was one of the many participants who we interviewed during this re-
search. Many of the patients we spoke with reflected upon numerous instances in 
which they wished they could have had closer contact with their physician. Patients 
noted feeling alone during this long and difficult journey. Given the demands on a 
physician’s time, patients reported that they felt uncomfortable sharing updates on 
their condition or requesting information because they did not want to be a nuisance. 
Patients also regularly failed to measure key indicators (e.g., weight and temperature) 
due to the lack of real-time and personalized reminders between hospital visits (which 
could be 21–30 days apart). Thus, their ability to manage their care on a regular basis 
was limited. 
The sentiments expressed by the cancer patients we interviewed are not surprising. 
Research shows that care models that are successful at improving outcomes and re-
ducing costs succeed in enhancing patient and family engagement in self-care and 
coordinating care and communication among patients and providers [1]. For example, 
                                                        
1 The quotes are translated from Italian. 
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Singh, Drouin [2] conducted a scoping review2 and found that self-management is 
essential to caring for high-need, high-cost populations. Furthermore, Hong, Siegel 
[3] found that successful care management programs 1) consider care coordination to 
be one of their key roles, 2) focus on building trusting relationships with patients and 
their primary care providers, 3) match the team composition and interventions to pa-
tient needs, 4) offer specialized training for team members, and 5) use technology to 
bolster their efforts. In general, patient understanding, trust, and clinician-patient 
agreement affect intermediate outcomes (e.g., increased adherence and better self-care 
skills) that in turn affect the health and well-being of the patient [4]. 
Identifying interventions capable of improving self-care and coordination with 
health care providers for cancer patients is a topic of growing importance in that 
chronic diseases, such as cancer, are a major reason for increased healthcare spending 
[5]. Among chronic diseases, cancer is the second leading cause of mortality and was 
responsible for 8.8 million deaths in 2015. Globally, nearly one in six deaths is due to 
cancer [6]. We focus on lung cancer, which is the most common cancer worldwide, 
accounting for 1.8 million new cases and more than 1.6 million deaths per year – 
more than breast, colon and prostate cancers combined [7].  
In this paper, we investigate the use of mobile phones, one of the most accessible 
forms of IT that has served as a platform for significant innovations that have impact-
ed almost all aspects of society. According to the Pew Research Centre’s 2017 report, 
more than three-quarters of American adults (77%) now own a smartphone, but the 
fastest growing demographic is people over 50, 74% of whom now own a device. In 
recent years, the emergence of mobile health apps in health care management has 
helped to overcome geographical and organizational barriers to improve health care 
delivery [8]. In 2018, approximately 50% of mobile phone users had at least one mo-
bile health app on their mobile phones [9].  
Studies stress the importance of stakeholder input in mHealth application devel-
opment for them to reach their potential. Unfortunately, many mHealth apps are de-
signed without considering the needs of either patients or clinicians [10]. The litera-
ture lacks empirically validated guidelines or process models on how to design apps 
with stakeholders rather than for stakeholders [11]. We utilize a design science ap-
proach to develop a mobile app for lung cancer patients that facilitates their interac-
tion with their clinicians, manages and reports on their health status, and provides 
them access to medical information/education. Our approach co-creates the IT artefact 
in collaboration with cancer patients and clinicians, who are the two important stake-
holders. Our four aims are as follows: 1) identify what functionality is to be included 
in the mHealth app so the app is valuable for healthcare processes (improving patient-
clinician relationships and the effectiveness of care delivery); 2) design an mHealth 
app that is valuable for patients and clinicians and includes them at the center of the 
design process; 3) test, redesign, and evaluate the validity of the mHealth app; and 4) 
identify generic design guidelines that can be utilized for the creation of mHealth apps 
for the management of chronic diseases. After completing the research process de-
                                                        
2 For details on the scoping review, please see 
http://hlwiki.slais.ubc.ca/index.php/Scoping_reviews  
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fined above, we conducted a reflective examination of our findings and identified 
emergent themes that we further developed into design guidelines. These design 
guidelines summarize what we learned from the design-testing-redesign evaluation 
cycles of our artefact and represent actionable knowledge that is grounded in evidence 
from the field.   
2 Background  
mHealth can be particularly important to cancer patients receiving treatments because 
they experience one or more side effects that can have a profound effect on their qual-
ity of life [12] and can also lead to dose delays, dose reductions, reductions in dose 
density and, in some cases, dose discontinuation. This reduces the effectiveness of 
chemotherapy and leads to worsening health for the patients [13]. Furthermore, these 
patients substantially increase the utilization of healthcare resources through increased 
hospitalization, emergency room visits, and the adoption of palliative treatments and 
ultimately increase the care-giving burden, which results in increased costs for 
healthcare systems, patients and care givers.  
Mobile monitoring devices could allow patients who experience severe symptoms 
to measure and record their health conditions and send the data electronically to phy-
sicians or specialists without delay, which also empowers patients to increase their 
self-confidence and self-management [14]. Currently, mHealth solutions are used for 
limited purposes in cancer care, with a prevailing focus on treatment activities [15]. 
This underutilization may be due to several factors, including environmental, regula-
tory, technological, and organizational elements [14] or the distinctive characteristics 
of the target populations (patients and clinicians). For example, consumers are con-
cerned about the use of their data when using mobile devices for health-related activi-
ties, which dilutes the potential to collect real-world data for research and develop-
ment. Some medical doctors fear that mHealth may jeopardize the patient-physician 
relationship and increase their workload [16]. Providers are reluctant to adopt 
mHealth technologies unless these services are adequately reimbursed [17]. Huckvale 
and Car also noted that apps are normally designed without considering the needs of 
their users, including both patients and clinicians [10]. In fact, despite the important 
role physicians play in the success of mHealth initiatives, little empirical research has 
examined how physicians use mHealth to manage patient health outcomes [18].   
3 Design-Test-Re-Design: The Case of LuCApp 
We designed, tested, redesigned and evaluated LuCApp, an mHealth app for lung 
cancer. Our research process is described in Figure 1.  
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Fig. 1. Research Process 
 
We distributed two surveys targeting two populations of mHealth application stake-
holders – randomly selected cancer clinicians and patients who use Internet-enabled 
mobile devices, such as smartphones. The two survey instruments were developed 
after consulting the literature and previous experiments on mHealth3. The results from 
the survey were shared with several stakeholder groups to solicit input and feedback. 
An international workshop was organized in Milan on April 8, 2016, to facilitate in-
teractions with more than 100 stakeholders, including patients, clinicians, app devel-
opers, the pharmaceutical and medical technology industries, telecom industries, ex-
perts in medical communications and health education, payers and policymakers.  
The feedback from the workshop was used to develop a set of questions that we 
posed to an expert roundtable. The roundtable consisted of four participants who rep-
resented two leading patients’ and clinicians’ associations based in Europe and the 
USA. The aim was to gather more specific insights and suggestions about the design 
and development of a lung cancer app. The discussion was moderated by a member of 
the research team. The roundtable was recorded and later transcribed for analysis. The 
moderator utilized probing questions to solicit suggestions from the participants con-
cerning three main themes: 1) information content, 2) interface design, and 3) usabil-
ity. The roundtable results were in turn used to create an interview script that was 
utilized to conduct five in-depth interviews with oncologists from different Italian 
hospitals. The participants included four oncologists that specialized in lung cancer 
                                                        
3 The study survey is available upon request. Citation blinded for review. 
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and one clinician that specialized in cancer palliative care4. Each interview lasted 
approximately 60 minutes, was recorded and was analyzed by two independent coders 
using content analysis to identify the main themes. The clinicians helped us identify a 
specific type of cancer patient who could benefit from an mHealth app – patients 
diagnosed with small or non-small cell lung cancer that were eligible for chemothera-
py, immunotherapy or biological therapy.  
We defined the requirements our mHealth application for supporting patients af-
fected by lung cancer under treatment with chemotherapy, immunotherapy or biologi-
cal therapy, LuCApp. It was designed with four main purposes: 
1) Improve the patient’s quality of life (QoL) by helping to achieve better manage-
ment of side effects caused by cancer therapies. 
2) Achieve earlier detection of any worsening of the disease by bridging the gap 
between clinicians and outpatients. 
3) Reassure patients by providing them with a means for supporting their continuity 
of care (which is particularly important for fragile persons). 
4) Improve the efficiency of the healthcare system by the real-time acquisition of 
critical data that can be useful for the clinician during patient visits. The app 
helps to collect and synthesize data for use by clinicians during a visit, which 
saves unnecessary collection time during appointments.  
4 LuCApp Development 
The app was developed by an IT firm in collaboration with the team of researchers 
involved in this study. The preliminary version of the app was built for both the iOS 
and Android platforms. The lung cancer application was designed and developed to 
be used in Italy; thus, all of its features and functions are in Italian. Figure 2 shows the 
main screen of the app. LuCApp also includes automatic alerts, reminders and tips 
that complement the patient’s therapy. The app was developed to comply with EU 
privacy regulations and the General Data Protection Regulation (GDPR). In addition, 
the development followed all of the guidelines from the Apple Store Review Guide-
lines and Android Market Guidelines. There are two versions of the app, one for cli-
nicians and one for patients. After the feasibility assessment, the first prototype was 
released to the research team for trial and feedback. The overall development effort, 
which lasted eight months, was performed utilizing DevOps methods [19] to provide 
the following for all nine releases in parallel: integration with the validated platform, 
full execution of the full test suite, quality control (according to European regulatory 
standards), and release reliability. By leveraging DevOps approaches, the team of 
researchers obtained rapid feedback throughout the development, test, and implemen-
tation processes, allowing them to evaluate all proposed improvements iteratively. In 
turn, the research team contributed feedback, thereby accelerating the review process 
in both the Apple and Android stores. 
 
                                                        
4 Palliative care is any treatment that focusses on reducing symptoms, improving quality of 
life, and supporting patients and their families. 
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Fig. 2. – Screenshot of LuCApp. 
5 LuCApp Test and Redesign Using the Exploratory Focus 
Group 
After careful consideration of several possible techniques that would allow us to test, 
redesign and evaluate our LuCApp, we decided to use focus groups that consist of 
oncologists and patients [20]. The focus groups allowed us to probe them on key ideas 
– specifically, on the functionality and usefulness of the app. Furthermore, the interac-
tion between the respondents allows for key insights that normally do not surface with 
other techniques. Tremblay, Hevner [20] described two types of focus groups: explor-
atory focus groups (EFGs) for the design and improvement of an artefact and con-
firmatory focus groups (CFGs) for evaluating the application in the field. We used the 
EFGs to provide feedback for the improvement of the design of the lung cancer appli-
cation. In the second phase, no additional changes were made to the lung cancer ap-
plication, and the CFGs were used to evaluate the app for usability and usefulness.  
For the EFGs (as well as for the CFGs), the planning process included creating a 
carefully planned script. The main topics of both EFGs included understanding i) how 
using a mobile health app as part of the routine practice of managing cancer patients 
could affect how clinicians monitor and evaluate patient health outcomes and their 
decision-making process and ii) how the app could affect patient quality of life and 
the quality of services offered by healthcare institutions. Before each focus group, the 
moderators introduced the project, explained the objectives and provided general 
information about the focus group. Furthermore, possible improvements to the app 
were agreed upon, which was aimed at refining the app before the final release.  
Specifically, sample screenshots were used to gather users’ feedback on the overall 
usability (e.g., layout, font size, and color) and attractiveness of the functions (e.g., 
content and design). The focus group script was divided into several parts reflecting 
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the main operational implications from a clinician’s perspective (the script is in Italian 
and is available upon request). The focus groups (both the EFGs and the CFGs) were 
recorded and professionally transcribed. The transcripts were analyzed using comput-
er-assisted qualitative data analysis software (CAQDAS). After the initial coding had 
highlighted relevant discussion themes, all of the text segments were iteratively ana-
lyzed. Themes were added or merged until they effectively represented all of the text 
segments and captured the essence of the discussion. The coding frame was refined 
with discussions about areas of disagreement and consensus, and any differences in 
interpretation were reconciled by the authors (the inter-rater reliabilities were 78% for 
EFG1, 76% for EFG2).   
5.1 Feedback from Clinician Exploratory Focus Groups (EFG1 and EFG2) 
The clinicians in both EFGs agreed that LuCApp could improve their ability to evalu-
ate the patient’s condition. Most of the focus group participants made similar com-
ments and discussed several instances in which this app would be useful in their daily 
activities. The clinicians particularly appreciated the possibility of being informed in 
real time by patients about their symptoms and about the severity of their symptoms; 
this timeliness would allow them to quickly contact the patients and make suggestions 
for next steps. Furthermore, clinicians found the “trend” component of the app of 
major importance.  One doctor focused on how the use of the app could change cur-
rent standards, highlighting that instead of using email and WhatsApp, this approach 
could be a more systematic, innovative and effective solution. However, one clinician 
in the second focus group noted that the effectiveness of the solution could depend 
upon the stage of the disease and the type of cancer; patients often have serious symp-
toms, and as they become worse, it would be difficult for them to use LuCApp by 
themselves. 
The findings from the clinicians can be summarized in two categories: functionali-
ty and usefulness. In terms of functionality, it was clear that the navigation and struc-
ture of the app must be evident for both patients and clinicians. Regarding the useful-
ness of the app, physicians want the ability to evaluate patient progress and monitor 
patient symptoms; they felt that they could improve the patient’s quality of life if the 
app provided mechanisms to reassure the patient. It is also important to them that the 
app integrate all necessary clinical information. Finally, the physicians want the app 
to give them the ability to continuously evaluate patient progress and monitor patient 
symptoms.  
5.2 Feedback from Patient Exploratory Focus Groups (EFG3) 
The patients stated that LuCApp reminded them of a powerful diary that they could 
fill in every day and share in real time with clinicians. The clinicians could then ac-
cess the patient’s information and be in contact with the patient when necessary. The 
patients also emphasized the relevance of symptom monitoring. This functionality 
would provide a mechanism to collect data that could be used to improve therapeutic 
treatment plans, not only for themselves but also for other patients now and in the 
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future. The patients noted that LuCApp would make them feel safer. By using Lu-
CApp, they would be able to communicate their symptoms in real time in cases when 
the symptoms were mild, moderate, severe or extreme. This ability is particularly 
important when patients have mild and moderate symptoms that could be serious but 
are not usually communicated to the clinician. The participants stated that this report-
ing could also help advance science; clinicians could learn what mild and moderate 
symptoms could lead to adverse outcomes. 
An important emergent theme is how LuCApp could influence the patient's rela-
tionship with caregivers. Stressing the importance of keeping their caregivers in the 
loop, some participants suggested that it could be useful to create a login and pass-
word to LuCApp for them to access important information about the patient’s care. 
This ability would be helpful in reassuring the caregivers, particularly when the it is a 
spouse or son/daughter. The participants indicated that LuCApp would improve their 
relationship with the clinicians because the clinicians would be able to access all of 
the data and information in real time. The participants were aware that the app would 
not substitute for real contact with the clinicians during regular checks but felt that 
LuCApp would keep the clinician better informed and updated about what is happen-
ing with the patient.  
We considered this initial feedback about the app from the patient EFG and partic-
ularly what this might mean for our design guidelines. Regarding the functionality and 
usefulness of the app, we learned from the patients that: 1) the navigation and struc-
ture must be clear; 2) the app must use fonts and colors that are appealing to patients; 
3) patient quality of life can be improved if the app provides mechanisms to reassure 
the patient; and 4) the app must facilitate communication between clinician and pa-
tients. 
5.3 Redesign of LuCApp 
The comments on user needs and preferences and app functionality and usefulness 
from all three exploratory focus groups were classified using the following themes: 
content and information (e.g., features, functions and relevant symptoms), navigation 
and structure, and design and presentation (e.g., use of color, graphics, and amount of 
text). The considerations for selecting which modifications to apply included the 
number of participants who mentioned the app, the context of use, overlap/integration 
with existing information and technical feasibility.  
6 LuCApp Evaluation Using Confirmatory Focus Groups 
The same panel of clinicians was included in the two clinician EFGs. However, a new 
panel of patients was involved in CFG3. Like the EFGs, the CFGs were recorded and 
professionally transcribed (the inter-rater reliabilities were 79% for CFG2 and 77% 
for CFG3). We applied the same demo approach described for the EFGs; illustrating 
the revised version of the mobile app based on the comments and suggestions re-
ceived in the EFGs. The participants were presented with a new list of symptom defi-
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nitions. The list that was previously presented during the EFGs was revised and sim-
plified using less medical jargon, a suggestion made by the clinicians during the EFGs 
to make the list less difficult for patients to understand. The clinicians (who had also 
participated in the EFGs) said the new labels were very clear. Moreover, the patients 
agreed even though they did not consider this issue to be a major one to be fixed be-
cause they considered themselves familiar with medical wording, and the issue was 
part of a single case; they did not request a specific modification to simplify the word-
ing. The clinicians in EFG2 had suggested the elimination of graphs and trends be-
cause they were worried that they would unnecessarily scare the patient (e.g., if they 
saw that they vomited three times in one week). When we raised the issue to a differ-
ent panel of clinicians (CFG1), they initially did not understand why the change was 
necessary, but after explaining the reasons, they eventually agreed that showing pa-
tients this type of information was of little use and could have a negative effect on 
their quality of life. 
Conversely, EFG3 (patients) was enthusiastic about the trends section, finding it 
one of the most useful functions. When we presented this functionality to CFG3 (pa-
tients), we asked them to decide whether to keep the trends functionality or to remove 
it. We explained that the clinicians were worried that this information could scare or 
stress them. The patients did not agree with the clinicians and were in complete con-
cordance with the patient EFG. They felt that the trend section was one of the most 
important and relevant features. The research team decided to keep this functionality 
in the latest version of LuCApp. Based on results from this phase, we conclude that 
the app was well received by the users. 
7 Design Guidelines  
We derived three categories of design guidelines based on a reflexive examination of 
the themes that emerged from the survey, workshop, roundtable, expert interviews 
and focus groups: design process, functionality and usefulness.  
Our process design guidelines indicate the fundamental role of stakeholders in the 
development of the app. Our two functionality design guidelines are related to the 
usability and attractiveness of an mHealth application. Three usefulness design guide-
lines indicate the functionality necessary in the mHealth application to achieve our 
goal – better coordination in the management of chronic disease.  
 
Design Process 
DG1: Stakeholder involvement. Stakeholders must be involved not only in the re-
quirement gathering stage but also throughout the entire iterative design process. Di-
rect and active interaction and cooperation between users and developers of the app 
enhances the quality, functionality, usability, design and utility. Different stakeholders 
might perceive information elements differently; thus, including different viewpoints 





Functionality of mHealth App 
DG2: Navigation and structure must be clear for both patients and clinicians. The 
typical lung cancer patient is elderly and needs an app that is easy to navigate through 
the different sections and screens (i.e., scroll systems should be used). Conversely, 
clinicians do not want to spend too much time searching for information. Ease captur-
ing of information (e.g., dropdown boxes) is important to minimize effort of use. 
DG3: Presentation must use fonts and colors that are appealing to patients. The typi-
cal lung cancer patient is elderly; thus, the font size and spacing of text should ensure 
good readability, the text for labels and buttons should be clear and concise, and the 
colors should provide good readability and good contrast. 
 
Usefulness of mHealth apps 
DG4: Ability to evaluate patient progress and monitor patient symptoms. Symptom 
descriptions should be simple and clear. Symptoms list should be accurate, complete 
and disease-specific. Functionality should include the ability to monitor and assess 
side effects caused by cancer therapies. 
DG5: Improve patient quality of life by providing mechanisms to reassure the patient. 
Provide the possibility of sharing patient’s symptoms and side effects with clinicians 
in order to receive rapid feedback about what to do and facilitate earlier detection of 
worsening disease. 
DG6: Integration of all clinical information. Provide the ability to port data directly 
into other systems and platforms they use. 
DG 7: Ease of communication between clinician and patients, including the ability for 
the clinician to view patient history 
8 Contributions 
In this study, we introduce a mixed-methods design process based on a combina-
tion of quantitative, qualitative, exploratory and evaluation activities, such as a sur-
vey, workshops, interviews, and focus groups. This approach allowed us to obtain 
nuanced understandings of both the clinicians’ and patients’ needs and of the chal-
lenges and intricacies of chronic disease management of a particularly complex 
chronic disease, lung cancer. Lung cancer patients tend to be elderly and have a high 
symptom burden, and the disease has both difficult and painful physiological and 
major psychological effects.  
As a team, we reflected that without following the design-test-redesign design sci-
ence approach highlighted in the paper, we likely would have developed a completely 
different app. The direct and active interaction and cooperation between the users and 
developers of the app enhanced its quality, functionality, usability, design and utility, 
as was emphasized during the interviews and the focus groups we conducted with the 
clinicians. The overall process of our research highlighted how a design science ap-
proach can be used to build useful mHealth applications using approaches that bolster 
user acceptance. We proposed a series of design guidelines that highlight the overall 
implications and contributions of this work. Our guidelines (or technological rules) 
were built as a reflective cycle [21]. We chose the case management of a chronic 
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disease, specifically, cancer. Our design guidelines were a result of the research team 
reflecting on our journey and can be categorized as design knowledge that can be 
tested and refined in subsequent cases in other chronic disease management contexts 
and/or be directly used by practitioners [21]. 
We acknowledge that in a perfect world, we would have had the opportunity to test 
the app live and collect feedback from a large number of users. However, we must 
reconcile this ideal with the realities of the world in which we live. The developed 
app was tested in a smaller group due to resource constraints. In addition, we believe 
that although the collected feedback might not be representative of every opinion of a 
potential user, is rich and informative. Another limitation of our study is that it was 
solely conducted in one country, Italy, which might hinder the generalizability of our 
results. Cultural beliefs and values might influence the opinions of both health profes-
sionals and patients. Therefore, further research is needed to investigate the validity of 
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